Pichl Daniel's most recent trade in SpringWorks Therapeutics Inc was a trade of 72,680 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on July 1, 2025.
Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
---|---|---|---|---|---|---|---|---|---|---|
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 72,680 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 65,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 64,000 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 50,762 | 0 (0%) | 0% | - | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 37,455 | 0 | - | - | Stock Option (Right to Buy) | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | Sale or transfer of securities back to the company at price $ 0.00 per share. | 01 Jul 2025 | 16,023 | 0 | - | - | Performance Share Units | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 16,000 | 80,512 (0%) | 0% | 27.6 | 442,240 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 16,000 | 32,750 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 13,750 | 66,762 (0%) | 0% | 53.0 | 728,998 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 13,750 | 64,512 (0%) | 0% | 27.6 | 380,050 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 13,750 | 31,250 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 9,000 | 57,762 (0%) | 0% | 54.3 | 488,260 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Feb 2025 | 7,000 | 50,762 (0%) | 0% | 57.2 | 400,072 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Jan 2025 | 37,455 | 37,455 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 10 Jan 2025 | 12,819 | 50,762 (0%) | 0% | 0 | Common Stock | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 04 Jan 2025 | 2,988 | 42,224 (0%) | 0% | 38.2 | 114,112 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 04 Jan 2025 | 2,522 | 39,702 (0%) | 0% | 38.2 | 96,315 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 04 Jan 2025 | 1,759 | 37,943 (0%) | 0% | 38.9 | 68,355 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 16 Feb 2024 | 15,000 | 45,212 (0%) | 0% | 50.1 | 751,550 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 16 Feb 2024 | 15,000 | 45,000 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 16 Feb 2024 | 15,000 | 60,212 (0%) | 0% | 27.6 | 414,600 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 02 Feb 2024 | 16,250 | 48,750 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 02 Feb 2024 | 16,250 | 71,393 (0%) | 0% | 27.6 | 449,150 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 02 Feb 2024 | 14,175 | 47,952 (0%) | 0% | 44.3 | 628,157 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 02 Feb 2024 | 9,266 | 62,127 (0%) | 0% | 43.8 | 405,942 | Common Stock | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | 02 Feb 2024 | 1,997 | 45,955 (0%) | 0% | 45.9 | 91,756 | Common Stock | |
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | 02 Feb 2024 | 743 | 45,212 (0%) | 0% | 46.4 | 34,507 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 04 Jan 2024 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | 04 Jan 2024 | 22,919 | 58,122 (0%) | 0% | 0 | Common Stock | ||
SpringWorks Therapeutics Inc | Pichl Daniel | Chief People Officer | 04 Jan 2024 | 1,574 | 56,548 (0%) | 0% | 38.0 | 59,749 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 04 Jan 2024 | 1,405 | 55,143 (0%) | 0% | 41.5 | 58,350 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 26 Jan 2023 | 858 | 35,203 (0%) | 0% | 31 | 26,598 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 07 Jan 2023 | 546 | 36,061 (0%) | 0% | 26.4 | 14,420 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 05 Jan 2023 | 65,000 | 65,000 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 05 Jan 2023 | 60,000 | 60,000 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 05 Jan 2023 | 19,425 | 38,326 (0%) | 0% | - | Common Stock | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 05 Jan 2023 | 1,719 | 36,607 (0%) | 0% | 27.5 | 47,307 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 07 Jan 2022 | 631 | 21,667 (0%) | 0% | 56.1 | 35,374 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 06 Jan 2022 | 40,710 | 40,710 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 06 Jan 2022 | 13,062 | 22,298 (0%) | 0% | - | Common Stock | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 08 Sep 2021 | 2,320 | 72,680 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 08 Sep 2021 | 2,320 | 9,236 (0%) | 0% | 43.1 | 99,992 | Common Stock | |
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 07 Jan 2021 | 33,200 | 33,200 | - | - | Stock Option (Right to Buy) | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 07 Jan 2021 | 4,150 | 4,150 (0%) | 0% | 0 | Common Stock | ||
SpringWorks Therapeutics Inc | Daniel Pichl | Chief People Officer | 03 Aug 2020 | 75,000 | 75,000 | - | - | Stock Option (Right to Buy) |